Clinical trial
An Evaluation of Effectiveness and Safety of the CorPath® GRX System in Endovascular Embolization Procedures of Cerebral Aneurysms
NCT04236856 is registered in ClinicalTrials.gov with Siemens Healthineers Endovascular Robotics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Evaluation of Effectiveness and Safety of the CorPath® GRX System in Endovascular Embolization Procedures of Cerebral Aneurysms
- Lead sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 21, 2020
- Completion date
- October 12, 2022
- Enrollment
- 120 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.